Rocephin and Moviprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate). Common drug interactions include anaemia among females and delirium among males.

The phase IV clinical study analyzes what interactions people have when they take Rocephin and Moviprep. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

On Jul, 26, 2026

13 people who take Rocephin and Moviprep together, and have interactions are studied.

Rocephin and Moviprep drug interactions.

What are the common drug interactions of Rocephin and Moviprep, by gender? *:

female:

Anaemia (lack of blood)
Asthenia (weakness)
Blood albumin decreased
Blood bilirubin increased
Confusional state
Eosinophilia (eosinophil count in the peripheral blood exceeds)
International normalised ratio increased
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Multi-organ failure (multisystem organ failure)
Pulmonary alveolar haemorrhage (acute bleeding)

male:

Delirium (wild excitement)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Panic attack
Pulmonary embolism (blockage of the main artery of the lung)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Asthenia (weakness)
General physical health deterioration (weak health status)

What are the common drug interactions of Rocephin and Moviprep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Mucosal inflammation (infection of mucous membrane)

10-19:

n/a

20-29:

Delirium (wild excitement)
Colitis ulcerative (inflammation of colon with ulcer)
Pain
Pyrexia (fever)
Asthenia (weakness)
General physical health deterioration (weak health status)
Post procedural complication
Syncope (loss of consciousness with an inability to maintain postural tone)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

n/a

40-49:

Anxiety
Chronic kidney disease
Depression
Gout (uric acid crystals building up in the body)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Panic attack
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

50-59:

Blood bilirubin increased
Confusional state
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pyrexia (fever)
Asthenia (weakness)
Blood albumin decreased

60+:

Pulmonary embolism (blockage of the main artery of the lung)
Anaemia (lack of blood)
Haemoglobin decreased
International normalised ratio increased
Multi-organ failure (multisystem organ failure)
Pulmonary alveolar haemorrhage (acute bleeding)
Thrombocytopenia (decrease of platelets in blood)
Tumour flare (temporary increase in symptoms from a cancer after starting treatment)

What are the existing conditions these people have? *

Pain: 8 people, 61.54%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 3 people, 23.08%
Constipation: 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
High Blood Cholesterol: 3 people, 23.08%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Cough: 2 people, 15.38%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 15.38%
Diabetes: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and Moviprep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously